Christoph H. Westphal, President and CEO at Flex Pharma, Inc. (FLKS), bought 60,218 shares at $9.80 ($599K) on 2016-05-09, disclosed to the SEC on 2016-05-11.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.80 | 17,532 | $172K | 28.7% |
| 2 | $9.80 | 17,532 | $172K | 28.7% |
| 3 | $10.14 | 12,577 | $128K | 21.3% |
| 4 | $10.14 | 12,577 | $128K | 21.3% |
| Total | $9.94 avg | 60,218 | $599K | 100% |
| Filing → |
| FLKS | BUY | 2016-11-08 | $51K | — | Filing → |
| FLKS | BUY | 2016-11-07 | $51K | — | Filing → |
| FLKS | BUY | 2016-06-24 | $30K | — | Filing → |